Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1975 Jan;146(1):285–287. doi: 10.1042/bj1460285

Stimulation of the pathway of porphyrin synthesis in the liver of rats and mice by griseofulvin, 3,5-Diethoxycarbonyl-1,4-dihydrocollidine and related drugs: evidence for two basically different mechanisms.

F De Matteis, A H Gibbs
PMCID: PMC1165300  PMID: 1147902

Abstract

Griseofulvin and isogriseofulvin cause, like 3,5-diethoxycarbonyl-1,4-dihydrocollidine, a fall in the activity of the hepatic enzyme porphyrin-metal chelatase and accumulation of protoporphyrin in the liver. Analogues of either griseofulvin or 3,5-diethoxycarbonyl-1,4-dihydrocollidine which do not decrease the chelatase activity are not porphyrogenic on their own, but can potentiate the porphyria caused by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. This suggests the existence of two basically different mechanisms by which drugs stimulate the pathway of porphyrin synthesis in the liver.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbritti G., De Matteis F. Decreased levels of cytochrome P-450 and catalase in hepatic porphyria caused by substituted acetamides and barbiturates. Importance of the allyl group in the molecule of the active drugs. Chem Biol Interact. 1972 Mar;4(4):281–286. doi: 10.1016/0009-2797(72)90022-1. [DOI] [PubMed] [Google Scholar]
  2. BEDFORD C., CHILD K. J., TOMICH E. G. Spectrophotofluorometric assay of griseofulvin. Nature. 1959 Aug 1;184(Suppl 6):364–365. doi: 10.1038/184364a0. [DOI] [PubMed] [Google Scholar]
  3. Badawy A. A., Evans M. The effects of chemical porphyrogens and drugs on the activity of rat liver tryptophan pyrrolase. Biochem J. 1973 Dec;136(4):885–892. doi: 10.1042/bj1360885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bock K. W., Weiner R., Fröhling W. Regulation of delta-aminolevulinic acid synthetase by drugs and steroids in isolated perfused rat liver. Enzyme. 1973;16(1):295–301. doi: 10.1159/000459393. [DOI] [PubMed] [Google Scholar]
  5. Chang R. L., Symchowicz S., Lin C. C. Oxidative demethylation of 14C-griseofulvin by liver microsomes of rats and mice. Biochem Pharmacol. 1973 Jun 1;22(11):1389–1392. doi: 10.1016/0006-2952(73)90314-6. [DOI] [PubMed] [Google Scholar]
  6. De Matteis F., Abbritti G., Gibbs A. H. Decreased liver activity of porphyrin-metal chelatase in hepatic porphyria caused by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Studies in rats and mice. Biochem J. 1973 Jul;134(3):717–727. doi: 10.1042/bj1340717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. De Matteis F. Drug interactions in experimental hepatic porphyria. A model for the exacerbation by drugs of human variegate porphyria. Enzyme. 1973;16(1):266–275. doi: 10.1159/000459390. [DOI] [PubMed] [Google Scholar]
  8. De Matteis F. Drugs and porphyria. S Afr Med J. 1971 Sep 25;:126–133. [PubMed] [Google Scholar]
  9. De Matteis F., Gibbs A. Stimulation of liver 5-aminolaevulinate synthetase by drugs and its relevance to drug-induced accumulation of cytochrome P-450. Studies with phenylbutazone and 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Biochem J. 1972 Mar;126(5):1149–1160. doi: 10.1042/bj1261149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lochhead A. C., Dagg J. H., Goldberg A. Experimental griseofulvin porphyria in adult and foetal mice. Br J Dermatol. 1967 Feb;79(2):96–102. doi: 10.1111/j.1365-2133.1967.tb11463.x. [DOI] [PubMed] [Google Scholar]
  11. Marks G. S., Hunter E. G., Terner U. K., Schneck D. Studies of the relationship between chemical structure and porphyria-inducing activity. Biochem Pharmacol. 1965 Jul;14(7):1077–1084. doi: 10.1016/0006-2952(65)90037-7. [DOI] [PubMed] [Google Scholar]
  12. ONISAWA J., LABBE R. F. Effects of diethyl-1, 4-dihydro-2, 4,6-trimethylpyridine-3,5-dicarboxylate on the metabolism of porphyrins and iron. J Biol Chem. 1963 Feb;238:724–727. [PubMed] [Google Scholar]
  13. Padmanaban G., Rao M. R., Malathi K. A model for the regulation of delta-aminolaevulinate synthetase induction in rat liver. Biochem J. 1973 Aug;134(4):847–857. doi: 10.1042/bj1340847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Racz W. J., Marks G. S. Drug-induced porphyrin biosynthesis. IV. Investigation of the differences in response of isolated liver cells and the liver of the intact chick embryo to porphyria-inducing drugs. Biochem Pharmacol. 1972 Jan 15;21(2):143–151. doi: 10.1016/0006-2952(72)90264-x. [DOI] [PubMed] [Google Scholar]
  15. Tschudy D. P., Bonkowsky H. L. Experimental porphyria. Fed Proc. 1972 Jan-Feb;31(1):147–159. [PubMed] [Google Scholar]
  16. Wada O., Yano Y., Urata G., Nakao K. Behavior of hepatic microsomal cytochromes after treatment of mice with drugs known to disturb porphyrin metabolism in liver. Biochem Pharmacol. 1968 Apr;17(4):595–603. doi: 10.1016/0006-2952(68)90275-x. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES